Immunotherapy for Alzheimer’s disease

bracu.degree.levelUndergraduate
bracu.type.groupStudent Works
datacite.rightsOpen Access
dc.contributor.advisorHaque, Dr. Md. Aminul
dc.contributor.authorRine, Sadia Islam
dc.contributor.departmentSchool of Pharmacy
dc.date.accessioned2024-04-24T05:09:20Z
dc.date.available2024-04-24T05:09:20Z
dc.date.copyright2022
dc.date.issued2022-02
dc.descriptionCataloged from PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 51-54).
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.en_US
dc.description.abstractAlzheimer's disease is one kind of a brain disorder which has the capability to destroy a person’s memory and thinking ability. To treat this disease various types of immunotherapies are required. This review is basically focused on finding of the immunotherapies that has been currently used for treating the Alzheimer’s disease. Immunotherapy is a kind of treatment for a disease to stimulate the immune system. Thus, immunotherapies have become most prominent to prevent the Alzheimer’s disease. In this literature review it has been shown that in most of the cases active, passive, tau and amyloid-beta immunotherapies are being used to prevent the risk of Alzheimer’s disease. To conclude it can be inferred that, this review might help the reader to know about the immunotherapies of Alzheimer disease however for getting better treatment in AD new treatment strategies need to be established.en_US
dc.description.degreeBachelor of Pharmacy
dc.description.statementofresponsibilitySadia Islam Rine
dc.format.extent54 pages
dc.identifier.otherID: 17346062
dc.identifier.urihttp://hdl.handle.net/10361/22663
dc.language.isoen_USen_US
dc.publisherBRAC Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectAlzheimer diseaseen_US
dc.subjectImmunotherapyen_US
dc.subjectTau pathologyen_US
dc.subjectAmyloid betaen_US
dc.subjectNeurodegenerativeen_US
dc.subjectDementiaen_US
dc.subject.lcshAlzheimer's disease--Treatment.
dc.titleImmunotherapy for Alzheimer’s diseaseen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
17346062_PHR.pdf
Size:
1.35 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: